Teva Pharmaceutical (Germany) Investor Sentiment

TEV Stock  EUR 21.20  0.20  0.95%   
Roughly 52% of Teva Pharmaceutical's stockholders are presently thinking to get in. The analysis of current outlook of investing in Teva Pharmaceutical Industries suggests that some traders are interested regarding Teva Pharmaceutical's prospects. The current market sentiment, together with Teva Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
Teva Pharmaceutical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Teva daily returns and investor perception about the current price of Teva Pharmaceutical Industries as well as its diversification or hedging effects on your existing portfolios.
  
over six months ago at news.google.com         
Teva Pharmaceutical Industries shareholders have earned a 54 percent return over the last year - Yah...
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries to Release Quarterly Earnings on Wednesday - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Revenue per Share CHF12.95 - GuruFocus.com
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Limited is a favorite amongst institutional investors who own 65 perc...
Google News at Macroaxis
over six months ago at news.google.com         
Zacks Research Analysts Boost Earnings Estimates for Teva Pharmaceutical Industries Limited - Market...
Google News at Macroaxis
over six months ago at news.google.com         
Israels Teva back in top pharmaceutical rankings - The Jerusalem Post
Google News at Macroaxis
over six months ago at news.google.com         
Sequoia Financial Advisors LLC Purchases 5137 Shares of Teva Pharmaceutical Industries Limited - Def...
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Sees Unusually Large Options Volume - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Ltd. Moves 7.5 percent Higher Will This Strength Last - Yahoo Movies ...
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Limited Shares Sold by AdvisorNet Financial Inc - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Assenagon Asset Management S.A. Purchases 507568 Shares of Teva Pharmaceutical Industries Limited - ...
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Limited Expected to Post Q3 2025 Earnings of 0.61 Per Share - MarketB...
Google News at Macroaxis
over six months ago at news.google.com         
Zacks Research Analysts Boost Earnings Estimates for Teva Pharmaceutical Industries Limited - Market...
Google News at Macroaxis
over six months ago at news.google.com         
Teva on track for seventh straight day of gains - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Has A Somewhat Strained Balance Sheet - Simply Wall St
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Teva Pharmaceutical that are available to investors today. That information is available publicly through Teva media outlets and privately through word of mouth or via Teva internal channels. However, regardless of the origin, that massive amount of Teva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Teva Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Teva Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Teva Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Teva Pharmaceutical alpha.

Teva Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance